Induction of autophagy restores the loss of sevoflurane cardiac preconditioning seen with prolonged ischemic insult. by Shiomi, Mayumi et al.
Thomas Jefferson University
Jefferson Digital Commons
Cardiology Faculty Papers Department of Cardiology
2-5-2014
Induction of autophagy restores the loss of
sevoflurane cardiac preconditioning seen with
prolonged ischemic insult.
Mayumi Shiomi
Osaka Medical College
Masami Miyamae
Osaka Dental University
Genzou Takemura
Gifu University Graduate School of Medicine
Kazuhiro Kaneda
Osaka Dental University
Yoshitaka Inamura
Osaka Dental University
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/cardiologyfp
Part of the Cardiology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Cardiology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Shiomi, Mayumi; Miyamae, Masami; Takemura, Genzou; Kaneda, Kazuhiro; Inamura, Yoshitaka;
Onishi, Anna; Koshinuma, Shizuka; Momota, Yoshihiro; Minami, Toshiaki; and Figueredo, M.D.,
Vincent M., "Induction of autophagy restores the loss of sevoflurane cardiac preconditioning seen
with prolonged ischemic insult." (2014). Cardiology Faculty Papers. Paper 58.
http://jdc.jefferson.edu/cardiologyfp/58
Authors
Mayumi Shiomi; Masami Miyamae; Genzou Takemura; Kazuhiro Kaneda; Yoshitaka Inamura; Anna Onishi;
Shizuka Koshinuma; Yoshihiro Momota; Toshiaki Minami; and Vincent M. Figueredo, M.D.
This article is available at Jefferson Digital Commons: http://jdc.jefferson.edu/cardiologyfp/58
  
Induction of Autophagy Restores the Loss of Sevoflurane Cardiac 
Preconditioning Seen with Prolonged Ischemic Insult 
 
 
 
Mayumi Shiomi*, Masami Miyamae†, Genzou Takemura&, Kazuhiro Kaneda#, Yoshitaka 
Inamura
#
, Anna Onishi#, Shizuka Koshinuma#, Yoshihiro Momota#, Toshiaki Minami*, 
Vincent M. Figueredo¶ 
 
 
 
 
*Department of Anesthesiology, Osaka Medical College, Osaka, Japan 
†Departments of Internal Medicine and #Anesthesiology, Osaka Dental University, Osaka, 
Japan, &Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, 
Japan and ¶Institute for Heart and Vascular Health, Einstein Medical Center, and Jefferson 
Medical College, Philadelphia, USA 
 
. 
 
 
Corresponding Author & Reprints: Masami Miyamae, MD, PhD 
Department of Internal Medicine,  
Osaka Dental University 
8-1 Kuzuha hanazono-cho Hirakata, 
Osaka 573-1121, Japan 
TEL: 81-72-864-3079, FAX: 81-72-864-3179 
E-mail: miyamae0907@gmail.com 
 
 
Short running title: Sevoflurane preconditioning and autophagy 
  
Abstract 
Background: Sevoflurane preconditioning (SPC) against myocardial ischemia-reperfusion 
injury is lost if the ischemic insult is too long. Emerging evidence suggests that induction of 
autophagy may also confer cardioprotection against ischemia-reperfusion injury. We 
examined whether induction of autophagy prolongs SPC protection during a longer ischemic 
insult. 
Methods: Isolated guinea pigs hearts were subjected to 30 or 45 min ischemia, followed by 
120 min reperfusion (control). Anesthetic preconditioning was elicited with 2% sevoflurane 
for ten minutes prior to ischemia (SEVO-30, SEVO-45). Chloramphenicol (autophagy 
upregulator, 300 µM) was administered starting 20 min before ischemia and throughout 
reperfusion in SEVO-45 (SEVO-45+CAP). To inhibit autophagy, 3-methyladenine 
(3MA:10 µM) was administered during sevoflurane administration in SEVO-45+CAP. 
Infarct size was determined by triphenyltetrazolium chloride stain. Tissue samples were 
obtained before ischemia to determine autophagy-related protein (microtubule-associated 
protein light chain I and II: LC3-I, II), Akt and glycogen synthase kinase 3β (GSK3β) 
expression using Western blot analysis. The effect of autophagy on calcium-induced 
mitochondrial permeability transition pore (MPTP) opening in isolated calcein-loaded 
mitochondria was assessed. Electron microscopy was used to detect autophagosomes. 
Results: Infarct size was significantly reduced in SEVO-30, but not in SEVO-45. 
Chloramphenicol restored SPC lost by 45 min ischemia. There were more abundant 
autophagozomes and LC3-II expression was significantly increased in SEVO-45+CAP. 
Induction of autophagy before ischemia enhanced GSK3β phosphorylation and inhibition of 
calcium-induced MPTP opening. These effects were abolished by 3MA. 
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Conclusions: Pre-ischemic induction of autophagy restores SPC lost by longer ischemic 
insult. This effect is associated with enhanced inhibition of MPTP by autophagy.  
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Introduction  
Experimental1-3 and clinical studies4,5 have demonstrated the use of volatile 
anesthetics as an additional therapeutic approach in the care of patients at risk of developing 
perioperative cardiac complications; known as volatile anesthetic preconditioning.6,7 The 
washout time of volatile anesthetics prior to ischemia8 and the duration of sustained 
ischemia9,10 have been shown to be crucial to successful volatile anesthetic cardioprotection. 
Kevin et al. demonstrated that sevoflurane cardioprotection is restricted to a range of 
ischemic durations of 25-40 min in isolated guinea pig hearts.9 Similarly, the neuroprotective 
effects of clinically relevant sevoflurane concentrations was observed only for ischemia of 
≤30 minutes.10 Finding strategies that prolong cardioprotection by sevoflurane 
preconditioning during longer ischemic insults could be clinically useful.  
Autophagy is a catabolic process through which damaged or long-lived protein and 
organelles are degraded using lysosomal degradative pathways. This is an evolutionally 
conserved process crucial for normal tissue homeostasis. Autophagy is considered one mode 
of cell death, termed “autophagic cell death”. Certainly, necrosis and apoptosis contribute to 
cardiomyocyte death in ischemia-reperfusion injury. However, accumulating evidence 
suggests that autophagy is stimulated by ischemia and may contribute to cardiomyocyte 
survival.12,13 Yet, excessive self-digestion and degradation of essential cellular components 
by autophagy could be detrimental.14 To date, it is unclear whether upregulation of 
autophagy is protective or detrimental for ischemic myocardium.  
Autophagy is triggered by opening of mitochondrial permeability transition pores 
(MPTP), which also play an important role in myocardial ischemia-reperfusion injury.15 
Studies have shown that inactivation of glycogen synthase kinase 3β (GSK3β) by 
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phosphorylation at Ser9 inhibits MPTP opening and protects cardiomyocytes against 
ischemia-reperfusion injury.16 It is not known whether pre-ischemic induction of autophagy 
affects MPTP. We hypothesized that pre-ischemic induction of autophagy restores loss of 
sevoflurane preconditioning seen with prolonged ischemic insult and this effect is associated 
with MPTP opening. Elucidating the role of autophagy in ischemia-reperfusion injury and 
finding strategies that prolong cardioprotection by sevoflurane preconditioning during longer 
ischemic insults could prove clinically useful in patients at cardiovascular risk during 
perioperative periods. 
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Methods 
This study was conducted in accordance with the Guidelines for Animal Research at 
Osaka Dental University with approval of the Animal Experiment Committee of Osaka 
Dental University, Osaka, Japan. These guidelines conform to the Guide for the Care and 
Use of Laboratory Animals from the National Academy of Science. Male Hartley guinea 
pigs were fed Lab Diet (RC4, Oriental Yeast, Tokyo, Japan) and water ad libitum. 
Chloramphenicol was purchased from Calbiochem (La Jolla, CA, USA) to induce 
autophagy. 3-methyladenine (3MA) was purchased from Sigma Aldrich (Ann Arbor, MI, 
USA) to inhibit autophagy.  
 
Isolated Heart Perfusion and Measurement of Function 
Guinea pigs (550-700g; 12-13 weeks old) received heparin (1000 units 
intraperitoneally), then were anesthetized with pentobarbital (60 mg-1kg-1, intraperitoneally). 
Hearts were excised and arrested in cold iso-osmotic saline containing 20 mM KCl. The 
aorta was cannulated and hearts were perfused at 70 mmHg on a nonrecirculating 
isovolumic perfusion apparatus, using Krebs-Henseleit perfusate, and paced at 240 
beats/min.3 Left ventricular developed pressure (LVDP) was measured using a 2.5 French, 
high-fidelity micromanometer (Nihon-Kohden, Tokyo, Japan) passed into a compliant latex 
balloon, inserted into the left ventricle, and recorded on a PowerLab 2/20 Data Recording 
System (ADInstruments, Hayward, Australia). The balloon was connected to a Y-adapter 
with one end used to advance the micromanometer and the other to fill the left ventricular 
balloon with bubble-free water to an end-diastolic pressure (LVEDP) of 10 mmHg. 
Coronary flow (CF) (mlmin-1g-1) was measured by collecting effluent. Global ischemia 
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was achieved by clamping the aortic inflow line. During ischemia, hearts were maintained at 
37 °C by enclosure in a water-jacketed air chamber. Warmed perfusate in the lower part of 
the chamber saturated the air with humidity and prevented cooling by evaporation. Heart 
temperature was continuously monitored by a digital thermometer (PTW-100A, Unique 
Medical, Tokyo, Japan). Sevoflurane was insufflated passing the 95%O2/5%CO2 gas 
mixture through a calibrated vaporizer (ACOMA, Tokyo, Japan). Coronary perfusate 
samples were collected anaerobically from the aortic cannula for measurement of 
sevoflurane concentration by an organic vapor sensor (OSP, Saitama, Japan). 
 
Experimental Protocol 
Animals were assigned 10 groups (n=8 each; Figure 1). After 20 min equilibration, 
baseline LVDP, LVEDP and CF were recorded. Hearts were subjected to 30 min (control; 
CTL-30) or 45 min (control; CTL-45) ischemia followed by 120 min reperfusion. 
Anesthetic preconditioning was elicited by administration of sevoflurane (2%) for 10 min 
followed by 10 min washout before 30 min or 45 min ischemia (SEVO-30, SEVO-45). For 
induction of autophagy, chloramphenicol (300 µM) was administered starting 20 min before 
45 min ischemia and throughout reperfusion in sevoflurane-treated (SEVO-45+CAP) or 
non-sevoflurane-treated animals (CAP-45) hearts. To inhibit autophagy, 3MA (10 µM) was 
administered during sevoflurane administration for 20 min in SEVO-45+CAP (SEVO-
45+CAP+3MA) and its vehicle (saline) in CTL-45 (CTL-45+3MA) (Figure 1). 
Chloramphenicol was dissolved in distilled water and 3MA was dissolved in 0.04% ethanol, 
to final concentrations of 300 µM and 10 µM, respectively.  
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Determination of Myocardial Infarct Size 
At experiment end, hearts were frozen at –80 °C for 15 min, then sliced into 2 mm 
thick transverse sections from apex to base (6 slices/heart). After defrosting, slices were 
incubated at 37 °C with 1% triphenyltetrazolium chloride (Sigma Chemicals, USA) 
photographed, and necrotic area was determined using Adobe Photoshop® CS (Adobe, San 
Jose, CA, USA) as previously described.3 
 
Western Blot Analysis 
     Separate experiments were performed (n=4 per group) to examine expression of 
autophagy-related protein (microtubule-associated protein light chain I and II: LC3-I, II), Akt, 
GSK3β and cyclophilin D. Myocardial tissue samples were collected before ischemia, and 
homogenized in ice-cold homogenizing buffer as previously described.3 Homogenate was 
centrifuged at 1000g for 5 min at 4 °C. Supernatant was re-centrifuged at 10000g for 15 min at 
4 °C to obtain cytosolic fraction. The pellet was designated as crude mitochondrial fraction 
and was resuspended in homogenizing buffer with 1% TritonX-100, incubated on ice for 1hr, 
then re-centrifuged at 10000g for 15 min at 4 °C. The resulting supernatant was used as 
mitochondrial fraction. Protein concentration was estimated with a Bradford assay. Equivalent 
amounts (20 µg) of protein samples were loaded and separated on 10% SDS-PAGE gradient 
gel, then electrically transferred overnight to a polyvinylidene difluoride membrane (Bio-Rad, 
Hercules, CA). After blocking with 5% skim milk in Tris-buffered saline containing 0.1% 
Tween-20 (TBS-T), membranes were incubated for 2 h at 4 °C in TBS-T containing 5% skim 
milk and overnight with 1:200-1000 dilution of rabbit primary antibody for LC3 (Medical & 
Biological Laboratories Co LTD, MA, USA), phospho Akt (Ser47), phospho GSK3β (Ser9) 
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(Cell Signaling TECHNOLOGY, Boston, MA, USA) and cyclophilin D (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). Membranes were incubated with a 1:1000 dilution of 
horseradish peroxidase–labeled anti-rabbit immunoglobulin G (NA 934V, GE Healthcare, 
Buckinghamshire, United Kingdom). The same blot was stripped and re-blotted with α-tubulin 
antibodies (Santa Cruz Biotechnology), total Akt and GSK3β (Cell Signaling 
TECHNOLOGY). Bound antibody signals were detected with enhanced chemiluminescence 
(Pierce Biotechnology, Rockford, IL, USA) and visualized using VersaDoc 5000 Imaging 
System (Bio-Rad, Hercules, CA). Quantitative analysis of band densities was performed with 
Quantity One software (Bio-Rad). Results are presented as the ratio of phospho Akt and 
phospho GSK3β to total (including non-phosphorylated and phosphorylated protein) Akt and 
GSK3β, respectively.  
 
Studies in isolated cardiac mitochondria 
To investigate involvement of MPTP in cardioprotection by autophagy, mitochondria 
were isolated (n=4 per group). After perfused and treated with sevoflurane, chloramphenicol 
and 3MA, isolated hearts were removed from the Langendorff apparatus, and homogenized 
in ice-cold MSTEB buffer as previously described.17 Extracted mitochondria were diluted in 
ice-cold respiratory buffer and incubated with 1µM calcein-AM (Invitrogen Molecular 
Probes, Carlsbad, USA) for 15 min at room temperature. Calcein-AM readily enters the 
mitochondria and is trapped in the matrix in its free form, which is fluorescent. After calcein 
was trapped in mitochondria, mitochondria were washed by KCl buffer.17 Calcein-loaded 
mitochondria were treated with 50 and 150 µM Ca++ per milligram of protein, and were 
incubated for 10 min at room temperature. Mitochondrial fluorescences were acquired. Flow 
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cytometric analysis was performed on FACS calibur™ (Becton Dickinson, Franklin lakes, 
NJ). Mitochondria labeled with calcein-AM were analyzed by flow cytometry in an 
instrument equipped with a 488 nm excitation source. 
 
Electron Microscopy 
To confirm induction of autophagy, cardiac specimens were obtained before 
sustained ischemia. They were fixed with phosphate-buffered 2.5 % glutaraldehyde (pH 7.4) 
and were postfixed with 1 % osmium tetroxide, after which they were conventionally 
prepared for transmission electron microscopy (H-800, Hitachi, Tokyo, Japan).  
 
Statistical Analysis 
Data are expressed as mean±SD. Statistical power analysis revealed a sample size of 
n=8 would provide sufficient power (0.8) to detect a difference between mean infarct size 
indices of 15 % (SD=9, α=0.05). A group size of n=4 was used for Western blot and calcein 
studies to provide a power of 0.8 to detect a difference between means of 20% (SD=10, 
α=0.05). Hemodynamic data were tested for normal distribution and subsequently analyzed 
by a two-factor repeated-measures analysis of variance for time and treatment. If an overall 
difference between variables was observed, comparisons were performed as one-way 
ANOVA followed by Tukey's post-hoc test for inter-group differences and by Dunnett's for 
intra-group differences with baseline values as the reference time point. Analyses of infarct 
size, Western blot and mitochondrial calcein fluorescence were performed using one-way 
ANOVA followed by Student's t-test with Bonferroni's correction for multiple comparisons 
to avoid type I error. For changes within and between groups a two-tailed p value less than 
0.05 was considered significant (SPSS17 for Windows, SPSS Japan, Tokyo, Japan).  
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Results 
Of 189 hearts, 7 were not used secondary to intractable ventricular fibrillation after 
reperfusion (3 in CTL-45, 2 in CAP-45, 1 in SEVO-45+3MA and 1 in  SEVO-
45+CAP+3MA) and one due to aortic rupture. Additional hearts were studied until each 
group had n=8 successful experiments for the infarct size study. The concentration of 
sevoflurane in the coronary perfusate after 10 min of exposure was 0.25±0.02 mM. 
Sevoflurane was not detected in the effluent during the baseline, ischemic, and reperfusion 
periods.  
 
Hemodynamics   
Baseline LVDP and CF were similar among the 10 groups. Sevoflurane, 
chloramphenicol or treatment with 3MA did not significantly affect LVDP or CF before 
ischemia. After 120 min reperfusion, only SEVO-30 had significantly higher LVDP and 
lower LVEDP compared to other groups. Treatment with 3MA alone did not affect the 
recovery of LVDP compared with CTL. There was no significant difference in CF among all 
the groups throughout experiments. This suggests that changes in CF could not account for 
improved contractile recovery in SEVO-30 (Table 1).         
 
Myocardial Infarct Size 
Myocardial infarct size in SEVO-30 was significantly reduced compared with control 
hearts (SEVO-30: 24±8% vs. CTL-30: 48±6%, p<0.05). However, this effect was lost when 
the ischemic period was extended to 45 min (SEVO-45: 53±6% vs. CTL-45: 54±11%, 
p=NS). Chloramphenicol restored protection lost by prolonged ischemia in SEVO-45 
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(SEVO-45+CAP: 34±8% vs. SEVO-45: 52±10%, p<0.05). Restoration of cardioprotection 
by chloramphenicol was abolished by 3MA (SEVO-45+CAP+3MA: 51±8% vs. CTL-45, 
p=NS). Treatment with chloramphenicol alone did not limit infarct size (CAP-45: 51±9%) 
(Figure 2).  
 
Electron Microscopy 
Figure 3 shows representative electron microphotographs. Although autophagic 
vacuoles were rarely seen in cardiomyocytes of CTL (panel A), typical autophagosomes 
containing intracellular organelles, such as mitochondria and membrane-like structures 
(white arrows), were apparent after sevoflurane administration (panel B). Additional 
treatment with chloramphenicol (panel C) further increased the number of autophagosomes. 
Autophagosomes were diminished by addition of 3MA (panel D). 
 
Western Blot analysis 
  In SEVO and CAP, LC3-II expression was increased compared with CTL. The 
combination of sevoflurane and chloramphenicol further increased this expression. These 
increased expressions of LC3-II were abolished by 3MA (Figure 4). The phosphorylation 
states of Akt and GSK3β after treatment with sevoflurane, cloramphenicol and 3MA are 
illustrated by a representative Western blot in Figure 5A. Total Akt and GSK3β were 
comparable in all samples. The ratio of phospho Akt to total Akt and phospho GSK3β to 
total GSK3β were significantly increased in SEVO and CAP compared with CTL (Figure 
5B). This increase was not caused by unequal loading of the western blot, as shown by α-
tubulin detection. The combination of sevoflurane and chloramphenicol enhanced these 
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increased expressions in SEVO-45+CAP. Administration of 3MA abolished these enhanced 
expressions in SEVO-45+CAP. There was no significant difference in expression of 
mitochondrial cyclophilin D between CTL and SEVO-45+CAP (Figure 5C). 
 
Mitochondrial calcein fluorescence 
  The mitochondrial calcein fluorescence values after treatment with Ca2+ were taken 
as the values from which any reduction in fluorescence was measured. Exposure of 
mitochondria to 50 µM Ca2+ did not induce MPTP opening (Figure 6A). However, exposure 
of mitochondria to 150 µM Ca2+ induced MPTP opening, represented by a reduction in 
calcein fluorescence of -66.9±13.0% in CTL. This Ca2+-induced reduction in calcein 
fluorescence was attenuated in the SEVO-45 and CAP-45 groups (-40.0±8.0%, -44.0±1.8% 
vs. CTL-45, p<0.05, respectively; Figure 6B). This effect was enhanced by the SEVO-
45+CAP (-15.5±0.3% vs. SEVO-45 and CAP-45, p<0.05), which was then abrogated by 
treatment with 3MA (SEVO-45+CAP +3MA: -74.6±7.8%) (Figure 6B). 
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Discussion 
This study demonstrated that induction of autophagy before ischemia restores the 
loss of sevoflurane preconditioning cardioprotection with prolonged ischemic insult. This 
effect is associated with enhanced phosphorylation of GSK3β before prolonged ischemia 
which results in elevation of the threshold of MPTP opening by Ca2+ overload, but not 
expression of mitochondrial cyclophilin D. There is a consensus that the use of volatile 
anesthetics during perioperative period could be a promising strategy to reduce ischemia-
reperfusion injury for patients at risk of developing cardiac complications. However, the 
beneficial effects of volatile anesthetics are limited to a certain range of sustained ischemia 
durations. Thus, strategies that prolong the protective effect of volatile anesthetics during 
longer ischemic insults should be explored. This study demonstrated for the first time that 
chloramphenicol treatment could be a novel strategy for this purpose. 
Chloramphenicol, used as an antibiotic, is a cytochrome P450 monooxygenase 
inhibitor which inhibits mitochondrial protein synthesis, causing mitochondrial stress. 
Chloramphenicol induces autophagy and preconditioning-like cardioprotection, but the 
mechanisms underlying the cardioprotective effect remains to be established. Thus, we 
examined whether treatment with chloramphenicol affects expression of mitochondrial 
cyclophilin D, which is a component of MPTP that controls mitochondrial pore-dependent 
Ca2+ exchange,18,19 and is a critical mediator of cardioprotection by ischemic 
preconditioning. There were no significant differences in expression of mitochondrial 
cyclophilin D between CTL and SEVO-45+CAP. This suggests that cyclophilin D is not 
involved in cardioprotection by chloramphenicol. Chloramphenicol stimulates the 
autophagic transcript Atg 12 by inhibiting mitochondrial protein synthesis, which results in 
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induction of autophagy.20 This study found that pretreatment with chloramphenicol before 
ischemia increased expression of LC3-II which leads to formation of autophagosomes. This 
was confirmed by electron microscopy.  
McCormick et al. demonstrated that enhancing autophagy confers protection against 
ischemia-reperfusion injury in cardiomyocytes.21 Using in vivo swine models, Sala-Mercado 
et al. showed that induction of autophagy by chloramphenicol before ischemia limited infarct 
size.22 However, the precise mechanisms by which pre-ischemic induction of autophagy 
confers cardioprotection remain to be elucidated. It has been demonstrated that induction of 
autophagy during ischemia is protective whereas further enhancement of autophagy is 
detrimental during reperfusion.23 Thus, it remains controversial whether autophagy is 
beneficial or harmful in ischemia-reperfusion injury.  
MPTP opening is a crucial determinant of ischemia-reperfusion injury.24 MPTP 
opening has also been shown to induce autophagy.25 Elmore et al. demonstrated that 
autophagic stimulation caused an increase in spontaneously depolarizing mitochondria 
(presumably transient MPTP opening) in rat hepatocytes.26 Transient MPTP opening before 
prolonged ischemia makes the heart more tolerant to ischemia-reperfusion injury.27,28 We 
previously demonstrated that heart exposure to sevoflurane increased the threshold of MPTP 
opening by Ca2+ loading.17 In the present study, exposure of control mitochondria to 150 µM 
Ca2+ induced MPTP opening. This was attenuated in CAP and SEVO, and attenuated to an 
even greater degree in SEVO+CAP. These data suggests that transient MPTP opening by 
induction of autophagy with chloramphenicol increases the elevation of the threshold of 
MPTP opening by sevoflurane alone.  
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The threshold for MPTP opening is increased by phosphorylation of GSK3β at Ser9 
through phosphatidylinositol 3-kinase (PI3K)/Akt signaling.16 Whether there is an 
association between autophagy and GSK3β phosphorylation in reducing ischemia-
reperfusion injury is not known. Recently, it was reported that ultraviolet B-induced 
autophagy activated AMP-activated protein kinase, an important regulator of autophagy 
through inhibition/phosphorylation of GSK3β.29 Our data demonstrated that induction of 
autophagy increased expression of phosphorylated GSK3β at Ser,9 accompanied by 
increased Akt phosphorylation. Both sevoflurane and chloramphenicol have been shown to 
activate PI3K/Akt signaling which is upstream of GSK3β.17,30 Class III PI3K is involved in 
the formation of autophagosomes, whereas class I PI3K inhibits the induction of autophagy 
via phosphorylation of Akt and the mammalian target of rapamycin (mTOR).31 Furthermore, 
there is evidence of self-regulation of autophagy by autophagy-induced inhibition of 
mTOR.32 Thus, the interaction of Akt with mTOR is multifaceted and bidirectional. 
Nevertheless, our data suggest that autophagy and PI3K-Akt-mTOR signaling might yield 
additive benefit against ischemia-reperfusion injury.  
In contrast to the in vivo porcine study by Sala-Mercado et al,22 chloramphenicol 
alone did not limit infarct size in the present study, despite increased expression of 
autophagy-related protein LC3-II. However, chloramphenicol-induced autophagy did 
prolong sevoflurane preconditioning cardioprotection after a longer ischemic insult. 
Although the reason for the discrepancy remains to be elucidated, differences in ischemia-
reperfusion model and species could play a role. 
The following study limitations should be acknowledged. First, GSK3β is a substrate 
of multiple pro-survival protein kinases. We cannot exclude ity that kinases other than 
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PI3K/Akt signaling contributed to enhanced phosphorylation of GSK3β. Second, the 
pharmacokinetics of 3MA are not well known, especially at high doses. The dose  of 3MA 
used in this study (10 µM) was low compared to previous studies (5 mM or 5 nM).21,29 
However, this dose has been shown to effectively block LC3-II expression in H9c2 cells as 
was seen in this study.33  
  In conclusion, induction of autophagy by before ischemia restores the loss of 
sevoflurane preconditioning cardioprotection with prolonged ischemic insult. This effect is 
associated with enhanced phosphorylation of GSK3β before prolonged ischemia which is 
associated with enhanced inhibition of MPTP opening.  
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                                                       Figure Legends 
Figure 1: Schematic illustration of the experimental protocol used in this study. There are ten 
groups. After 20 min baseline period, isolated perfused hearts were subjected to 30 or 45 min 
global ischemia and 120min reperfusion. Anesthetic preconditioning was elicited by 
administration of 10 min of SEVO (2%) with 10 min washout before 30 or 45 min ischemia. 
CAP and 3-MA was administered starting 20 min before 45 min ischemia and throughout 
the reperfusion period in hearts from SEVO-treated or non-SEVO-treated animals. Tissue 
samples were obtained before ischemia. CTL, control; CAP, Chloramphenicol; 3-MA, 3-
Methyladenine; SEVO, sevoflurane. 
 
Figure 2: Infarct size as a percentage of LV in ten groups. After 120min reperfusion, infarct 
size was significantly reduced in SEVO-30 but not in SEVO-45 compared to corresponding 
CTL. Treatment with CAP in SEVO-45 restored the protection lost by prolonged ischemia in 
SEVO-45. CAP alone did not limit infarct size after 45 min of ischemia. Restoration of 
cardioprotection achieved by CAP was abolished by 3MA. 3MA alone did not affect infarct 
size. Data are presented as mean ± SD; *p<0.05 versus CTL-30; †p<0.05 versus SEVO-45. 
CTL, control; CAP, Chloramphenicol; 3-MA, 3-Methyladenine; SEVO, sevoflurane (n=8 for 
each group). 
 
Figure 3: Electron microphotographs of cardiomyocytes, showing pre-ischemic induction of 
autophagosomes by reagents. Autophagosomes were rarely seen in the untreated control 
heart (panel A), were apparently observed (white arrows) after treatment with SEVO-45 
(panel B). Autophagosomes appear to be more abundant after additional treatment with CAP 
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(SEVO-45+CAP) compared with SEVO-45 alone (panel C). Appearance of autophagosomes 
strikingly diminished after treatment with 3MA (panel D). Nucl, nucleus. Bars, 1 µm. 
 
Figure 4: Representative western blot analysis of LC3-I, II from left ventricular samples 
obtained before ischemia. The expression of LC3-II was slightly increased in SEVO and 
CAP compared to CTL. The ratio of LC3-II to LC3-I (LC3-II/LC3-I) was further increased 
in SEVO-45+CAP compared to SEVO-45 and CAP-45. Administration of 3-MA abolished 
this increased LC3-II/I in the SEVO-45+CAP group. *p<0.05 versus CTL, †p<0.05 versus 
SEVO-45 and CAP-45; CAP, Chloramphenicol; LC3-I, II, microtubule-associated protein 
light chain I and II; 3-MA, 3-Methyladenine; SEVO, sevoflurane. 
 
Figure 5: (A) Representative western blot of phosphorylated GSK3β from left ventricular 
samples acquired before ischemia. Expression of phosphorylated GSK3β was significantly 
increased in the SEVO-45 and CAP-45 group. The combination of SEVO and CAP further 
increased this expression of phosphorylated GSK3β and Akt in the SEVO-45+CAP group. 
Administration of 3MA abolished this enhanced expression of phosphorylated GSK3β in the 
SEVO-45+CAP group.  
(B) Densitometric evaluation of four experiments as the x-fold increase in average light 
density vs. CTL. The results are presented as the ratio of the phosphorylation state to total 
protein. The average light intensity was multiplied by 100 to facilitate the presentation of an 
x-fold increase. Data are presented as mean standard deviation. *p<0.05 versus CTL-45, 
†p<0.05 versus SEVO-45, CAP-45 and SEVO-45+CAP+3MA 
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(C) Cytosolic and mitochondrial expression of cyclophilin D in CTL, CAP-45 and SEVO-
45+CAP. There was no significant difference in expression between the three groups.  
CTL, control; CAP, Chloramphenicol; CyF D, cyclophilin D; GSK3β, glycogen synthase 
kinase-3; 3-MA, 3-methyladenine; PHB, prohibitin; SEVO, sevoflurane. 
 
Figure 6: (A) Representative flow cytometric profile of isolated cardiac mitochondria loaded 
with calcein showing the effects of calcium (50 µM) on mPTP opening as demonstrated by 
reductions in mitochondrial calcein fluorescence. Exposure of mitochondria to 50 µM Ca2+ 
did not induce MPTP opening in any group. (B) Exposure of mitochondria to 150µM Ca2+ 
induced MPTP opening in CTL. This Ca2+-induced reduction in calcein fluorescence was 
attenuated in SEVO and CAP. This effect was enhanced by the combination of sevoflurane 
and chloramphenicol, which was then abrogated by treatment with 3MA. (C) Effect of 
calcium (150µM) on MPTP opening as demonstrated by reductions in mitochondrial calcein 
fluorescence. Data are mean ± S.D. Percent change from control in the presence or absence 
of 3-MA (10 µM). *p<0.05 versus CTL-45; †p<0.05 versus SEVO-45 and CAP-45 groups. 
CTL, control; CAP, Chloramphenicol; 3MA, 3-Methyladenine; SEVO, sevoflurane. n=4 for 
each group 
 
Figure 7: Schematic diagram of potential mechanisms of autophagy-induced 
cardioprotection conferred by chloramphenicol and sevoflurane. Phosphorylation of GSK3β 
by PI3-Akt pathway inhibits MPTP opening. Class III PI3K is involved in formation of 
autophagosomes whereas class I PI3K inhibits the induction of autophagy via 
phosphorylation of Akt and mTOR. Treatment with chloramphenicol or sevoflurane alone 
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activates class III PI3K to induce autophagy. Simultaneous treatment with chloramphenicol 
and sevoflurane enhances this pathway which results in enhanced phosphorylation of GSK3β 
and elevation of the threshold of MPTP opening.  
PI3K = phosphatidylinositol 3-kinase; Akt = protein kinase B; GSK3β = glycogen synthase 
kinase 3β; mTOR = mammalian target of rapamycin; MPTP = mitochondrial permeability 
transition pore. 
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Table 1 
 
TABLE 1. Hemodynamic Variables          
  Baseline  Reperfusion (min)    30 60 120 
LVDP (mmHg)                 
     CTL-30 109 ± 11  39 ± 8  32 ± 12  26 ± 9 
 
     SEVO-30 103 ± 13  61 ± 9*  58 ± 8*  50 ± 8*  
     CTL-45 108 ± 13  21 ± 6  25 ± 13  24 ± 9  
   SEVO-45 101 ± 10  23 ± 11  24 ± 10  23 ±   9  
     CAP+45 109 ± 11  21 ± 7  21 ±   6  21 ±   6  
     SEVO-45+CAP 101 ± 14  21 ± 5  22 ±   5  21 ±   4  
     CTL-45+3MA 117 ± 12  18 ±   6  20 ±   7  17 ± 6  
     SEVO-30+3MA 97 ± 14  44 ± 16 ̷  47 ± 17  44 ± 17  
     SEVO-45+3MA 95 ± 10  23 ± 15  24 ± 14  20 ± 16  
     CAP-45+3MA 105 ± 15  25 ± 11  23 ± 10  20 ± 10  
     CAP-45+SEVO+3MA 97 ± 11  19 ±  9  26 ± 16  26 ± 16  
LVEDP (mmHg)                 
     CTL-30 10 ± 0  47 ± 14  51 ± 18  55 ± 15  
     SEVO-30 10 ± 0  24 ± 7*   24 ± 5*  26 ± 7*  
     CTL-45 10 ± 0  67 ± 7  57 ± 13  53 ± 14  
     SEVO-45 10 ± 0  55 ± 13  50 ± 11  47 ± 12  
     CAP+45 10 ± 0  53 ± 10  48 ± 10  45 ± 10  
     SEVO-45+CAP 10 ± 0  53 ±   6  51 ± 10  49 ± 11  
     CTL-45+3MA 10 ± 0  68 ±   8  66 ± 10  66 ± 11  
     SEVO-30+3MA 10 ± 0  27 ± 7*  25 ± 9*  25 ± 9*  
     SEVO-45+3MA 10 ± 0  72 ± 19  62 ± 17  60 ± 19  
     CAP-45+3MA 10 ± 0  63 ± 12  57 ± 15  52 ± 19  
     SEVO-45+CAP+3MA 10 ± 0  59 ± 15  51 ± 15  44 ± 16  
CF (mL)                 
     CTL-30 28 ± 6   21 ± 5   21 ± 5   20 ± 8   
     SEVO-30 31 ± 7   23 ± 4   22 ± 5   22 ± 6   
     CTL-45 29 ± 7  18 ± 8  18 ± 10  18 ± 9  
     SEVO-45 28 ± 10  19 ± 11  17 ± 11  17 ± 11  
     CAP+45 28 ± 3  19 ±   5  18 ± 6  18 ± 7  
     SEVO-45+CAP 34 ± 4  18 ± 5  19 ± 9  19 ± 9  
     CTL-45+3MA 37 ± 6  20 ± 8  18 ± 8  18 ± 8  
     SEVO-30+3MA 29 ± 8  18 ± 7  19 ± 11  20 ± 11  
     SEVO-45+3MA 27 ± 5  13 ± 5  13 ± 5  11 ± 5  
     CAP-45+3MA 31 ± 9  20 ± 9  19 ± 9  19 ± 9  
     SEVO-45+CAP+3MA 31 ± 9  19 ± 7  19 ± 7  18 ± 6  
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Data are presented as mean ± SD. LVDP=left ventricular developed pressure; LVEDP=left 
ventricular end-diastolic pressure; CF=coronary flow; CTL=control;CAP=chloramphenicol; 
3MA=3-Methyladenine; SEVO=sevoflurane;. *p<0.05 vs. CTL-30, ̷ p<0.05 vs. SEVO-30 
n=8 for each group.  
 
 
 
  
 
29 
Figure 1 
 
 
  
 
30 
Figure 2 
 
 
  
 
31 
Figure 3 
 
 
  
 
32 
Figure 4 
 
 
  
 
33 
Figure 5 
 
 
  
 
34 
Figure 6 
 
  
 
35 
Figure 7 
 
 
 
